본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

실험적 포도막염에서 종양괴사인자 단일세포군항체의 치료 효과

이용수  2

영문명
Therapeutic Effects of Anti-Tumor Necrosis Factor Monoclonal Antibody on Experimental Uveitis
발행기관
대한안과학회
저자명
한은령 오민진 조민선 이지수 이정희,Eun-Ryung Han, M.D., Min-Jin Oh, M.D., Min-Seon Cho, M.D., Ji Soo Lee, M.D., Jeong-Hee Lee, M.D.
간행물 정보
『대한안과학회지』Ophthalmological Society,volume48,number8, 1143~1150쪽, 전체 8쪽
주제분류
의약학 > 기타의약학
파일형태
PDF
발행일자
2007.08.31
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: We investigated the therapeutic effects of monoclonal anti-TNF antibody (infliximab) on experimental uveitis. Methods: Twenty New Zealand White rabbits were immunized with Mycobacterium tuberculosis H37Ra antigen and then challenged with intravitreal injection of tuberculin antigen to introduce a uveitis. Then infliximab was injected into rabbit eyes at an intravenous concentration of 5 mg/kg and intravitreal concentrations of 1 mg/0.1mL and 100 microg/0.1mL. As a control, the vehicle was injected intravenously or intravitreally. To evaluate the therapeutic effects, inflammation was assessed by slit lamp biomicroscopy and scored according to the severity of inflammation. The animals were also evaluated by electroretinography and histopathology. Results: Regardless of the administration route, inflammatory activities of anterior chamber and engorgement of vascular structures were reduced in the infliximab treated group compared to control. Different administration routes and different concentrations of infliximab did not affect the therapeutic outcome of the clinical scoring. Intravenous (5 mg/kg) and intravitreal diluted (100 microg/0.1mL) infliximab injection groups showed significant improvement in electroretinographic findings and significant reduction of inflammatory cells with preservation of retinal tissue architecture on histopathologic examination. However, focal loss of the photoreceptor outer segment is observed in intravitreal undiluted (1 mg/0.1 mL) infliximab injected eyes. Conclusions: Infliximab may be a useful treatment modality to suppress ocular inflammation in experimental uveitis models in rabbits.

목차

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

한은령,오민진,조민선,이지수,이정희,Eun-Ryung Han, M.D., Min-Jin Oh, M.D., Min-Seon Cho, M.D., Ji Soo Lee, M.D., Jeong-Hee Lee, M.D.. (2007).실험적 포도막염에서 종양괴사인자 단일세포군항체의 치료 효과. 대한안과학회지, 48 (8), 1143-1150

MLA

한은령,오민진,조민선,이지수,이정희,Eun-Ryung Han, M.D., Min-Jin Oh, M.D., Min-Seon Cho, M.D., Ji Soo Lee, M.D., Jeong-Hee Lee, M.D.. "실험적 포도막염에서 종양괴사인자 단일세포군항체의 치료 효과." 대한안과학회지, 48.8(2007): 1143-1150

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제